Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study

Autor: Olieman, AFT, Lienard, D, Eggermont, AMM, Kroon, BBR, Lejeune, FJ, Hoekstra, HJ, Schraffordt Koops, H.

Publikováno v: Archives of Surgery, 134(3), 303-307. American Medical Association
Archives of Surgery, 134(3), 303-307. AMER MEDICAL ASSOC

Background: Hyperthermic isolated limb perfusion (HILP) with tumor necrosis factor alpha (TNF-alpha), interferon gamma, and melphalan has proved to be useful in the treatment of recurrent malignant melanoma and of locally advanced soft tissue sarcoma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::883330d2f919d4f160f0601e5f2075f6
https://pure.eur.nl/en/publications/ab79321e-4e4b-4660-ac9f-2ea42b7c1e14

Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial

Autor: Vaglini, M, Suciu, S, Kroon, BBR, Thompson, JF, Gohl, J, Eggermont, AMM, Di Filippo, F, Krementz, ET, Ruiter, D, Lejeune, FJ, Schraffordt Koops, H.

Publikováno v: Journal of Clinical Oncology, 16, 2906-2912
Journal of Clinical Oncology, 16(9), 2906-2912. American Society of Clinical Oncology
Journal of Clinical Oncology, 16, pp. 2906-2912
Journal of Clinical Oncology, 16(9), 2906-2912. AMER SOC CLINICAL ONCOLOGY

Purpose: Patients with primary cutaneous melanoma greater than or equal to 1.5 mm in thickness are at high risk of having regional micrometastases at the time of initial surgical treatment. A phase III international study was designed to evaluate whe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f4992126537160bd28638990e8b6b80b
http://hdl.handle.net/2066/188817

Principles and guidelines for surgeons: management of cutaneous malignant melanoma

Autor: Kroon, BBR, Nieweg, OE, Hoekstra, HJ, Lejeune, FJ

Publikováno v: European Journal of Surgical Oncology, 23(6), 550-558. ELSEVIER SCI LTD

this article outlines and discusses the principles of the guidelines for the management of malignant melanoma be surgeons, the guidelines art based, in large part, on the consensus of the Dutch Melanoma Working Party that was revised in 1997, The art

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::6d3e10e618e7f8191ad8cab22413a9dc
https://research.rug.nl/en/publications/eeb357e4-01ff-4685-8532-01d0619aa1f6

Isolated limb perfusion with high-dose tumor necrosis factor-alpha for locally advanced extremity soft tissue sarcomas

Autor: Eggermont, Lex, Schraffordt Koops, H, Klausner, JM, Schlag, PM, Kroon, BBR, Ben-Ari, G, Lejeune, FJ, Verweij, J.J., Pinedo, H.M., Suit, H.D.

Publikováno v: Soft tissue sarcomas: Present achievements and future prospects., 189-203
STARTPAGE=189;ENDPAGE=203;TITLE=Soft tissue sarcomas: Present achievements and future prospects.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::131897b6fe6391df69ca5f8918f5b606
https://pure.eur.nl/en/publications/c2ac3b46-a528-4ff7-8e4e-884c9cf67ec6

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial

Autor: Eggermont, AMM, Lienard, D, Kroon, BBR, vanGeel, AN, Hoekstra, HJ, Lejeune, FJ, Schraffordt Koops, H.

Publikováno v: Journal of Clinical Oncology, 14(10), 2653-2665. AMER SOC CLINICAL ONCOLOGY

Purpose: 16 determine the efficacy of isolated limb perfusion (ILP) with tumor necrosis factor-alpha (TNF) in combination with interferon-gamma (IFN) and melphalan as induction therapy to render tumors resectable and avoid amputation in patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::dffce30b964e68368bb921ab11adc925
https://research.rug.nl/en/publications/0f55f507-a1b7-4e57-a2ed-455c86b3971a